Developer docs
API playgroundTry for free, no card

Search company profiles

Hurdle

Full company profile

uuid00079rw

Namestring
Hurdle
Legal namestring
Chronomics Limited
Websiteurl
hurdle.bio
Company typeenum
Private
Founded yearint
2017
Descriptiontext

Hurdle (legal entity: Chronomics Limited) is a London-headquartered diagnostics-as-a-service (DaaS) company, founded in 2017 and rebranded from Chronomics in November 2023. With between 51 and 100 employees and a New York office, Hurdle operates a multi-omics AI biomarker discovery platform anchored in saliva-based next-generation sequencing (NGS) and proprietary epigenetic biomarkers, including the InflammAge inflammation-age marker and a biological-age test first commercialized in 2020. The platform processes samples via CE/UKCA-marked collection kits manufactured under ISO 13485, analyzed through a UKAS/CQC-accredited lab network, with a catalogue of more than 400 tests and a cumulative volume of over 3 million diagnostic tests processed. A data asset covering 2 million+ patient records and petabytes of multi-modal data feeds the proprietary Federated AI Discovery Engine and the recently launched AI Risk Scores product line. Hurdle holds 3 patents in epigenetics and maintains a stacked compliance posture including ISO 27001, SOC 2, HIPAA, GDPR, and ISO 13485.

The platform is delivered through an API with no-code/low-code integration options, complemented by a Digital Patient Experience Platform, Clinics OneDX, and a Partner Dashboard (with a new Partner Portal launched in March 2025). Hurdle serves enterprise B2B customers across private healthcare providers, telehealth operators, contract research organizations (CROs), consumer health brands, and employee benefits platforms. Named customers and partners include Bayer (flagship InflammAge partner), Lindus Health, Numan, Stride, Eurofins, GeneHub, Univi, Biovie, and the University of Birmingham. Hurdle has raised $2.8M in disclosed funding from Outsized Ventures (June 2023), which remains its only institutional round on record.

Short descriptiontext

Hurdle is a London-based diagnostics-as-a-service company that uses a multi-omics AI platform, a Federated AI Discovery Engine, and saliva-based NGS testing to deliver 400+ biomarkers and lab services to enterprise healthcare, telehealth, CRO, and consumer health customers across the UK, EU, and North America.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
diagnostic infrastructure, biomarker discovery, multi-omics analytics, epigenetic diagnostics, clinical lab testing
Industry4 codes
PRIMARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)
NAICS code6 codes
  • Scientific Research and Development Services5417
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
  • Medical Laboratories621511
  • Custom Computer Programming Services541511
  • Computer Systems Design Services541512
  • Testing Laboratories and Services54138
SIC code4 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
  • Services-Prepackaged Software7372
  • Services-Computer Programming, Data Processing, Etc.7370
Product category
Diagnostics-as-a-Service Platform
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model5 records
1Biomarker R&D Services
TypeProfessional Services
Description

Scientific consultancy and biomarker development services accelerating the biomarker discovery and validation process (3-10X faster than conventional approaches). Includes co-creation of custom biomarker panels with scientific and clinical teams.

hurdle.bio
2Diagnostics-as-a-Service (DaaS)
TypeManaged Services
Description

End-to-end diagnostic testing infrastructure delivered as a modular service. Covers sample collection kits, logistics & fulfilment, lab testing, digital patient experience, and partner dashboard — offered as an integrated suite or as plug-and-play components. Revenue is generated through the provision of the full platform or individual modules to enterprise partners.

hurdle.bio
3Sample Collection Kit Sales
TypeHardware Sales
Description

Branded test collection kits (CE marked) sold to healthcare providers, telehealth companies, and enterprise partners. Various kit types including blood, urine, saliva, stool, and more.

hurdle.bio
4Digital Medicine Platform Licensing
TypeLicensing Royalties
Description

White-labelled digital medicine solution enabling consumer health brands to integrate personalised diagnostics. Deployed as a platform licence with custom branding.

hurdle.bio
5Lab Testing Services
TypeSubscription Recurring
Description

Diagnostic test processing through a network of CQC/UKAS-accredited labs. Covers hundreds of test types across the UK and EU, with results delivered via the partner dashboard or white-labelled interface.

hurdle.bio
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels5 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details3 tiers
1Custom enterprise contracts — pricing based on scope of services, volume, and integration requirements
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Full end-to-end DaaS contracts are negotiated on a per-partner basis. Pricing varies by volume of tests, number of modules deployed, branding requirements, and service level.

hurdle.bio
2Modular plug-and-play — individual components (kits, lab testing, API, dashboard) priced per unit or per test
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual solutions such as sample collection kits or lab tests can be purchased separately, with pricing varying by test type and volume.

hurdle.bio
3Clinics OneDX — self-serve all-in-one diagnostics ordering system for healthcare providers
ModelSubscriptionBilling cadenceAnnual
Notes

All-in-one platform for clinics with no-code setup. Pricing details available upon contacting sales.

hurdle.bio
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 record
1DiscoverDx
Description

Multi-omics AI-powered biomarker discovery engine used in partnership with Bayer for developing novel diagnostics including the InflammAge biomarker.

hurdle.bio
Core offering1 text field

Hurdle combines AI-driven multi-omics biomarker R&D with an end-to-end Diagnostics-as-a-Service (DaaS) platform for enterprise healthcare customers. Its integrated offering spans proprietary biomarker discovery (DiscoverDx AI engine), CE/UKCA-marked custom-branded sample collection kit manufacturing, a UKAS/CQC-accredited lab testing network, logistics and fulfilment, a white-labelled digital patient experience, and a partner dashboard accessible via a unified API or no-code interface.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Hurdle offers a unified Diagnostics-as-a-Service (DaaS) platform that combines biomarker R&D (powered by DiscoverDx AI engine), sample collection kits (CE/UKCA marked), UKAS/CQC-accredited lab testing network, logistics and fulfilment, digital patient experience, and partner dashboard into a single integrated solution. The platform is designed for healthcare providers, telehealth companies, consumer health brands, clinical research organisations, and employee benefits consultants. Integration options include no-code (LabShop templates), low-code (customizable workflows), and full API access. The Test Catalogue provides 400+ clinically validated tests while the Federated AI Discovery Engine enables multi-institutional biomarker research without data centralization.

Product and service10 records
1Diagnostics-as-a-Service (DaaS) Platform
CategoryDiagnostic Platform
Description

End-to-end diagnostic testing infrastructure delivered as a modular managed service, covering biomarker R&D, custom-branded sample collection kits, UKAS/CQC-accredited lab testing, logistics and fulfilment, a white-labelled digital patient experience, and a partner dashboard — sold to healthcare providers, telehealth firms, CROs, pharma, and consumer health brands via custom enterprise contracts and the unified Hurdle API.

2Biomarker R&D Services
CategoryResearch & Development Services
Description

AI-driven biomarker discovery and validation services leveraging DiscoverDx and multi-omics datasets to identify and develop novel biomarkers for complex risk factors and diseases, supporting regulatory submissions for enterprise partners.

3Sample Collection Kits
CategoryMedical Devices / Hardware
Description

Custom-branded CE/UKCA-marked sample collection kits with validated accuracy covering blood, saliva, urine, stool, and swab specimen types, sold to healthcare providers, telehealth companies, and enterprise partners as standalone products or as part of DaaS programmes.

4Lab Testing Services
CategoryLaboratory Services
Description

Diagnostic test processing delivered through a hand-picked network of CQC/UKAS-accredited labs across the UK and EU, covering hundreds of test types with results delivered via the partner dashboard or white-labelled interface, sold as a standalone service or as part of DaaS.

5Clinics OneDX
CategoryHealthcare SaaS
Description

Self-contained, no-code all-in-one diagnostics ordering system designed for healthcare providers and clinics that do not have developers on staff, providing pre-built templates for rapid deployment and direct access to the Hurdle test catalogue.

6DiscoverDx Biomarker Discovery Engine
CategoryAI / Bioinformatics Platform
Description

Hurdle's proprietary multi-omics AI-powered biomarker discovery engine used to co-develop novel diagnostics with partners such as Bayer, accelerating biomarker R&D across genomic, epigenomic, proteomic, and lipidomic data.

7Hurdle Diagnostics API Platform
CategoryDeveloper API / Platform
Description

Robust REST API that powers the full end-to-end diagnostic testing workflow from ordering, billing, and fulfilment triggering to results delivery, integrated into partner systems with extensive developer documentation and support.

8Test Catalogue (400+ validated tests)
CategoryDiagnostic Test Catalogue
Description

Comprehensive catalogue of 400+ clinically validated diagnostic tests covering hormones, wellness, metabolic health, fertility, thyroid, liver function, vitamins, and specialty panels, available through the Hurdle partner portal and Clinics OneDX.

9InflammAge Saliva-Based Epigenetic Biomarker
CategoryEpigenetic Diagnostic Test
Description

Saliva-based epigenetic biomarker that quantifies chronic inflammation during human aging, co-developed by Hurdle and Bayer using the DiscoverDx engine, validated in the Generation Scotland biobank, and deployed as an at-home CE-marked diagnostic via the Hurdle DaaS platform.

10Epigenetic Biological Age Test
CategoryEpigenetic Diagnostic Test
Description

World's first saliva-based NGS epigenetic biomarker for quantifying biological age, developed by Hurdle scientists and deployed as a CE-marked diagnostic through the Hurdle DaaS platform and partner channels.

Scale indicator6 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierFlagship / CoreTypeStrategic or Co-development PartnerAnnounced on2023-01-01
Description

Bayer and Hurdle formed a strategic precision health partnership to develop and launch personalised diagnostics for healthy aging. Using Hurdle's DiscoverDx AI biomarker engine, the companies developed the InflammAge chronic inflammation biomarker, validated it in Generation Scotland (one of the world's largest epigenetic biobanks), and deployed it as an at-home saliva diagnostic via Hurdle's DaaS platform. Karl Wishart, Global R&D Emerging Science & Innovation Director at Bayer Consumer Health, described working with Hurdle for over 2 years on novel diagnostics co-development. The partnership created a scalable digital ecosystem for personalised health management.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Lindus Health partnered with Hurdle on clinical trials investigating treatments for pre-diabetes and flu. Hurdle provides decentralised diagnostic infrastructure enabling remote patient testing. Michael Young, Co-Founder at Lindus Health, described Hurdle as understanding the needs of health tech pioneers and being an incredible team to work with.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
1Tempus AI
TypeDirect peer
Description

US-based multi-omics AI platform combining genomic, transcriptomic and clinical data for biomarker discovery and diagnostics, selling to pharma, providers and CROs. Most directly comparable to Hurdle's DiscoverDx + DaaS positioning but at materially larger scale.

TypeBroad incumbent
Description

Established liquid-biopsy and multi-omics diagnostics company serving oncologists, biopharma and researchers. Comparable in multi-omics + clinical-decision-support use cases, and a likely competitor for Hurdle's pharma and CRO biomarker deals.

TypeBroad incumbent
Description

Roche-owned molecular diagnostics and multi-omics profiling company used by oncologists and biopharma for biomarker-driven treatment selection. Highly comparable in the biomarker discovery and pharma CDx space where Hurdle is building.

4Function Health
TypeDirect peer
Description

Consumer health platform offering a broad battery of diagnostic tests with personalised, longitudinal results. Comparable to Hurdle's white-label digital-medicine and consumer-health-brand offering, including the recurring-test, at-home model.

TypeDirect peer
Description

Direct-to-consumer epigenetic biological age test backed by academic research and partnerships. Closest conceptual competitor to Hurdle's saliva-based NGS biological-age biomarker and InflammAge chronic-inflammation biomarker.

TypeDirect peer
Description

Decentralised and hybrid clinical trial platform providing remote patient assessments, eCOA and connected diagnostics. Highly comparable to Hurdle's CRO segment, where it underpins decentralised trial diagnostics infrastructure.

TypeDirect peer
Description

UK-based at-home blood-testing and personalised health insights platform. Comparable in the UK consumer / private-provider diagnostic value chain, where Hurdle also offers at-home sample collection and partner-branded kits.

8Daye
TypeDirect peer
Description

UK-based diagnostic startup offering at-home vaginal and other sample collection kits with lab processing and digital follow-up. Comparable in the white-label / branded at-home kit + accredited lab + digital dashboard model.

9Genomics England
TypeRegional player
Description

UK government-backed organisation running large-scale genomic and multi-omic programmes linked to the NHS. Comparable to Hurdle's federated multi-omics work with biobanks such as Generation Scotland and the UK Biobank ecosystem.

TypeBroad incumbent
Description

Global clinical laboratory and diagnostics-services giant offering routine and specialty testing plus clinical trial and pharma development services. Comparable as both a potential lab-network partner and a competitor for enterprise diagnostic contracts.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers9 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature10 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance14 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors2 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hurdle

Diagnostics-as-a-Service Platformhurdle.bio

Hurdle is a London-based diagnostics-as-a-service company that uses a multi-omics AI platform, a Federated AI Discovery Engine, and saliva-based NGS testing to deliver 400+ biomarkers and lab services to enterprise healthcare, telehealth, CRO, and consumer health customers across the UK, EU, and North America.

What Hurdle does

Hurdle (legal entity: Chronomics Limited) is a London-headquartered diagnostics-as-a-service (DaaS) company, founded in 2017 and rebranded from Chronomics in November 2023. With between 51 and 100 employees and a New York office, Hurdle operates a multi-omics AI biomarker discovery platform anchored in saliva-based next-generation sequencing (NGS) and proprietary epigenetic biomarkers, including the InflammAge inflammation-age marker and a biological-age test first commercialized in 2020. The platform processes samples via CE/UKCA-marked collection kits manufactured under ISO 13485, analyzed through a UKAS/CQC-accredited lab network, with a catalogue of more than 400 tests and a cumulative volume of over 3 million diagnostic tests processed. A data asset covering 2 million+ patient records and petabytes of multi-modal data feeds the proprietary Federated AI Discovery Engine and the recently launched AI Risk Scores product line. Hurdle holds 3 patents in epigenetics and maintains a stacked compliance posture including ISO 27001, SOC 2, HIPAA, GDPR, and ISO 13485.

The platform is delivered through an API with no-code/low-code integration options, complemented by a Digital Patient Experience Platform, Clinics OneDX, and a Partner Dashboard (with a new Partner Portal launched in March 2025). Hurdle serves enterprise B2B customers across private healthcare providers, telehealth operators, contract research organizations (CROs), consumer health brands, and employee benefits platforms. Named customers and partners include Bayer (flagship InflammAge partner), Lindus Health, Numan, Stride, Eurofins, GeneHub, Univi, Biovie, and the University of Birmingham. Hurdle has raised $2.8M in disclosed funding from Outsized Ventures (June 2023), which remains its only institutional round on record.

Hurdle firmographics

Firmographics
Name
Hurdle
Legal name
Chronomics Limited
Website
https://hurdle.bio
Company type
Private
Founded year
2017
Operating status
Operating
Headcount range
51–100 employees
Short description
Hurdle is a London-based diagnostics-as-a-service company that uses a multi-omics AI platform, a Federated AI Discovery Engine, and saliva-based NGS testing to deliver 400+ biomarkers and lab services to enterprise healthcare, telehealth, CRO, and consumer health customers across the UK, EU, and North America.
Ownership category
akta.pro rank

Hurdle industry classification

Industry
Product category
Diagnostics-as-a-Service Platform
NAICS
Scientific Research and Development Services (5417), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Medical Laboratories (621511), Custom Computer Programming Services (541511), Computer Systems Design Services (541512), Testing Laboratories and Services (54138)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731), Services-Prepackaged Software (7372), Services-Computer Programming, Data Processing, Etc. (7370)
akta.pro industry
PRIMARYHLAAANAF
Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics)
SECONDARYHLAGAJAD
Bioinformatics & Multi-omics Analysis Software
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLAGAJAO
AI/ML Platforms for Drug Discovery & Experiment Optimization
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Life Science Software & Informatics (LIMS/ELN/Bioinformatics)
SECONDARYHLACANAF
SaMD – Digital Biomarkers & Algorithmic Endpoints
Healthcare & Life Sciences/Digital Health & Health IT/Digital Therapeutics (DTx) & Software as a Medical Device (SaMD)

Keywords

  • Diagnostic infrastructure
  • Biomarker discovery
  • Multi-omics analytics
  • Epigenetic diagnostics
  • Clinical lab testing

Where Hurdle is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices3 records

Markets served

Hurdle business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. Biomarker R&D Services: Scientific consultancy and biomarker development services accelerating the biomarker discovery and validation process (3-10X faster than conventional approaches). Includes co-creation of custom biomarker panels with scientific and clinical teams.
  2. Diagnostics-as-a-Service (DaaS): End-to-end diagnostic testing infrastructure delivered as a modular service. Covers sample collection kits, logistics & fulfilment, lab testing, digital patient experience, and partner dashboard — offered as an integrated suite or as plug-and-play components. Revenue is generated through the provision of the full platform or individual modules to enterprise partners.
  3. Sample Collection Kit Sales: Branded test collection kits (CE marked) sold to healthcare providers, telehealth companies, and enterprise partners. Various kit types including blood, urine, saliva, stool, and more.
  4. Digital Medicine Platform Licensing: White-labelled digital medicine solution enabling consumer health brands to integrate personalised diagnostics. Deployed as a platform licence with custom branding.
  5. Lab Testing Services: Diagnostic test processing through a network of CQC/UKAS-accredited labs. Covers hundreds of test types across the UK and EU, with results delivered via the partner dashboard or white-labelled interface.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractCustom enterprise contracts — pricing based on scope of services, volume, and integration requirements
Unit PricingPay-as-you-goModular plug-and-play — individual components (kits, lab testing, API, dashboard) priced per unit or per test
SubscriptionAnnualClinics OneDX — self-serve all-in-one diagnostics ordering system for healthcare providers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels7 records

Hurdle product offering

Product offering

Core offering

Hurdle combines AI-driven multi-omics biomarker R&D with an end-to-end Diagnostics-as-a-Service (DaaS) platform for enterprise healthcare customers. Its integrated offering spans proprietary biomarker discovery (DiscoverDx AI engine), CE/UKCA-marked custom-branded sample collection kit manufacturing, a UKAS/CQC-accredited lab testing network, logistics and fulfilment, a white-labelled digital patient experience, and a partner dashboard accessible via a unified API or no-code interface.

Product overview

Hurdle offers a unified Diagnostics-as-a-Service (DaaS) platform that combines biomarker R&D (powered by DiscoverDx AI engine), sample collection kits (CE/UKCA marked), UKAS/CQC-accredited lab testing network, logistics and fulfilment, digital patient experience, and partner dashboard into a single integrated solution. The platform is designed for healthcare providers, telehealth companies, consumer health brands, clinical research organisations, and employee benefits consultants. Integration options include no-code (LabShop templates), low-code (customizable workflows), and full API access. The Test Catalogue provides 400+ clinically validated tests while the Federated AI Discovery Engine enables multi-institutional biomarker research without data centralization.

Differentiator

Problem solved

Functional benefit

Brands

  • DiscoverDx: Multi-omics AI-powered biomarker discovery engine used in partnership with Bayer for developing novel diagnostics including the InflammAge biomarker.

Products and services

  • Diagnostics-as-a-Service (DaaS) Platform End-to-end diagnostic testing infrastructure delivered as a modular managed service, covering biomarker R&D, custom-branded sample collection kits, UKAS/CQC-accredited lab testing, logistics and fulfilment, a white-labelled digital patient experience, and a partner dashboard — sold to healthcare providers, telehealth firms, CROs, pharma, and consumer health brands via custom enterprise contracts and the unified Hurdle API.
  • Biomarker R&D Services AI-driven biomarker discovery and validation services leveraging DiscoverDx and multi-omics datasets to identify and develop novel biomarkers for complex risk factors and diseases, supporting regulatory submissions for enterprise partners.
  • Sample Collection Kits Custom-branded CE/UKCA-marked sample collection kits with validated accuracy covering blood, saliva, urine, stool, and swab specimen types, sold to healthcare providers, telehealth companies, and enterprise partners as standalone products or as part of DaaS programmes.
  • Lab Testing Services Diagnostic test processing delivered through a hand-picked network of CQC/UKAS-accredited labs across the UK and EU, covering hundreds of test types with results delivered via the partner dashboard or white-labelled interface, sold as a standalone service or as part of DaaS.
  • Clinics OneDX Self-contained, no-code all-in-one diagnostics ordering system designed for healthcare providers and clinics that do not have developers on staff, providing pre-built templates for rapid deployment and direct access to the Hurdle test catalogue.
  • DiscoverDx Biomarker Discovery Engine Hurdle's proprietary multi-omics AI-powered biomarker discovery engine used to co-develop novel diagnostics with partners such as Bayer, accelerating biomarker R&D across genomic, epigenomic, proteomic, and lipidomic data.
  • Hurdle Diagnostics API Platform Robust REST API that powers the full end-to-end diagnostic testing workflow from ordering, billing, and fulfilment triggering to results delivery, integrated into partner systems with extensive developer documentation and support.
  • Test Catalogue (400+ validated tests) Comprehensive catalogue of 400+ clinically validated diagnostic tests covering hormones, wellness, metabolic health, fertility, thyroid, liver function, vitamins, and specialty panels, available through the Hurdle partner portal and Clinics OneDX.
  • InflammAge Saliva-Based Epigenetic Biomarker Saliva-based epigenetic biomarker that quantifies chronic inflammation during human aging, co-developed by Hurdle and Bayer using the DiscoverDx engine, validated in the Generation Scotland biobank, and deployed as an at-home CE-marked diagnostic via the Hurdle DaaS platform.
  • Epigenetic Biological Age Test World's first saliva-based NGS epigenetic biomarker for quantifying biological age, developed by Hurdle scientists and deployed as a CE-marked diagnostic through the Hurdle DaaS platform and partner channels.

Companies that use Hurdle

Customer profile

Named customers9 records

Segments5 records

Ideal customer profiles6 records

Hurdle technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability8 records

Feature10 records

Hurdle partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered flagship / core and core.

  • Bayerflagship / coreStrategic or Co-development Partner · 1 January 2023Bayer and Hurdle formed a strategic precision health partnership to develop and launch personalised diagnostics for healthy aging. Using Hurdle's DiscoverDx AI biomarker engine, the companies developed the InflammAge chronic inflammation biomarker, validated it in Generation Scotland (one of the world's largest epigenetic biobanks), and deployed it as an at-home saliva diagnostic via Hurdle's DaaS platform. Karl Wishart, Global R&D Emerging Science & Innovation Director at Bayer Consumer Health, described working with Hurdle for over 2 years on novel diagnostics co-development. The partnership created a scalable digital ecosystem for personalised health management.
  • Lindus HealthcoreStrategic or Co-development PartnerLindus Health partnered with Hurdle on clinical trials investigating treatments for pre-diabetes and flu. Hurdle provides decentralised diagnostic infrastructure enabling remote patient testing. Michael Young, Co-Founder at Lindus Health, described Hurdle as understanding the needs of health tech pioneers and being an incredible team to work with.

Scale indicators6 records

Recent moves7 records

Expansion highlights6 records

Hurdle competitors and assessment

Company assessment

Direct peers

  • Tempus AI: US-based multi-omics AI platform combining genomic, transcriptomic and clinical data for biomarker discovery and diagnostics, selling to pharma, providers and CROs. Most directly comparable to Hurdle's DiscoverDx + DaaS positioning but at materially larger scale.
  • Function Health: Consumer health platform offering a broad battery of diagnostic tests with personalised, longitudinal results. Comparable to Hurdle's white-label digital-medicine and consumer-health-brand offering, including the recurring-test, at-home model.
  • Elysium Index: Direct-to-consumer epigenetic biological age test backed by academic research and partnerships. Closest conceptual competitor to Hurdle's saliva-based NGS biological-age biomarker and InflammAge chronic-inflammation biomarker.
  • Medable: Decentralised and hybrid clinical trial platform providing remote patient assessments, eCOA and connected diagnostics. Highly comparable to Hurdle's CRO segment, where it underpins decentralised trial diagnostics infrastructure.
  • Thriva: UK-based at-home blood-testing and personalised health insights platform. Comparable in the UK consumer / private-provider diagnostic value chain, where Hurdle also offers at-home sample collection and partner-branded kits.
  • Daye: UK-based diagnostic startup offering at-home vaginal and other sample collection kits with lab processing and digital follow-up. Comparable in the white-label / branded at-home kit + accredited lab + digital dashboard model.

Broad incumbents

  • Guardant Health: Established liquid-biopsy and multi-omics diagnostics company serving oncologists, biopharma and researchers. Comparable in multi-omics + clinical-decision-support use cases, and a likely competitor for Hurdle's pharma and CRO biomarker deals.
  • Foundation Medicine: Roche-owned molecular diagnostics and multi-omics profiling company used by oncologists and biopharma for biomarker-driven treatment selection. Highly comparable in the biomarker discovery and pharma CDx space where Hurdle is building.
  • Labcorp: Global clinical laboratory and diagnostics-services giant offering routine and specialty testing plus clinical trial and pharma development services. Comparable as both a potential lab-network partner and a competitor for enterprise diagnostic contracts.

Regional players

  • Genomics England: UK government-backed organisation running large-scale genomic and multi-omic programmes linked to the NHS. Comparable to Hurdle's federated multi-omics work with biobanks such as Generation Scotland and the UK Biobank ecosystem.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Hurdle social profiles

Digital presence

Hurdle compliance and trust

Trust signal

Compliance14 records

Hurdle financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hurdle leadership team

Management profile

Number of profiles

Profiles7 records

Hurdle funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors2 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hurdle M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hurdle

What does Hurdle do?

Hurdle combines AI-driven multi-omics biomarker R&D with an end-to-end Diagnostics-as-a-Service (DaaS) platform for enterprise healthcare customers. Its integrated offering spans proprietary biomarker discovery (DiscoverDx AI engine), CE/UKCA-marked custom-branded sample collection kit manufacturing, a UKAS/CQC-accredited lab testing network, logistics and fulfilment, a white-labelled digital patient experience, and a partner dashboard accessible via a unified API or no-code interface.

Is Hurdle a public or private company?

Hurdle is a private company. It is classified as venture growth investor backed and is currently operating.

When was Hurdle founded?

Hurdle was founded in 2017. It employs 51 to 100 people.

Where is Hurdle based?

Hurdle is headquartered in London, United Kingdom, in the Europe region.

How does Hurdle make money?

Five revenue lines are on record. Biomarker R&D Services are the primary driver. The others are diagnostics-as-a-Service (DaaS), sample Collection Kit Sales, digital Medicine Platform Licensing and lab Testing Services.

Who are Hurdle's main competitors?

Direct peers on record are Tempus AI, Function Health, Elysium Index, Medable, Thriva and Daye. Broad incumbents are Guardant Health, Foundation Medicine and Labcorp. Genomics England is listed as a regional player.

Does Hurdle have an API?

Yes. Hurdle provides a robust API that can power an entire end-to-end diagnostic testing workflow, from ordering, billing, and triggering fulfilment to delivering results. The API enables seamless integration into existing systems with extensive developer support and documentation. Developer documentation is at docs.hurdle.bio.

What industry is Hurdle in?

Hurdle's product category is Diagnostics-as-a-Service Platform. Its primary akta.pro industry code is HLAAANAF, Multi-Omics Precision Medicine Platforms (genomics/proteomics/metabolomics), with a secondary code of HLAGAJAD, Bioinformatics & Multi-omics Analysis Software. Its NAICS code is 5417 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Business Wire BlogBayer and Hurdle launch precision health strategic partnershipBayer and Hurdle launched a strategic partnership to advance precision health and aging. Bayer will sell Hurdle's saliva-based Chronomics Biological Age Test through direct-to-consumer e-commerce. The partnership integrates Hurdle's AI-powered biomarker discovery with Bayer's consumer health expertise.GlobeNewswireHurdle Partners with CloudLIMS To Augment Diagnostic Lab Capabilities, Marking a DaaS/SaaS First for LabsHurdle and CloudLIMS announced a strategic partnership integrating Hurdle's remote diagnostic platform with CloudLIMS's SaaS LIMS, enabling labs to offer at-home tests and manage data. The collaboration allows labs to automate workflows and meet regulatory compliance such as HIPAA, GDPR, CLIA, and ISO 15189:2022, with no upfront investment.HIT ConsultantHurdle, CloudLIMS Partner to Augment Diagnostic Lab CapabilitiesHurdle and CloudLIMS announced a strategic partnership integrating a Diagnostic as a Service platform with a SaaS LIMS. The collaboration enables partner labs to offer at-home tests and manage data while complying with HIPAA, GDPR, CLIA, and ISO 15189:2022. It aims to extend remote diagnostic services to underserved communities and improve offerings to B2B customers.GlobeNewswireHurdle Launches Vitamin D Test, Offering Lab-Quality Results from HomeHurdle announced general availability of its Vitamin D test, which requires a finger prick and returns results within three days. The test is sold online for $59 and is available to adult consumers, with about 35% of U.S. adults being Vitamin D deficient.GlobeNewswireHurdle Launches HbA1c Home Test for Early Detection of Diabetes in AdultsHurdle announced general availability of its HbA1c home test for adult diabetes screening, priced at $69. The test returns results within three days and is available on Chronomics's online store. Hurdle notes over 8.5 million American adults have undiagnosed diabetes.GlobeNewswireHurdle Launches At-Home Total Testosterone Test KitHurdle launched the Total Testosterone Test 1, an at-home finger-prick kit for measuring testosterone levels. The kit costs $69, with results from an accredited lab within 2-3 days. The test is available on the Chronomics online store.